ClinicalTrials.Veeva

Menu
O

Optimed Research, LTD | The Boster Center for Multiple Sclerosis

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Frexalimab
SAR441344
Ocrelizumab
BIIB091

Parent organization

This site is a part of Optimed Research, LTD

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study to Evaluate Safety and Efficacy of BIIB091 in Participants With Relapsing Forms of Multiple Sclerosis (FUSION)

The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

Trial sponsors

Sanofi logo
Biogen logo
Yale University logo
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems